Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Evansville
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Evansville, IN

Studies commonly pay $75 to $4,500 per completed study

66 clinical trials are currently recruiting participants within 30 miles of Evansville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

66studies recruiting
2+research centers nearby
7condition categories
Live from the NIH registry

Studies recruiting near Evansville right now

Top 25 of 66 recruiting studies, sorted by proximity — each links to its official registry page

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Atrial Fibrillation N/A Interventional 276 participants sought
Deaconess Gateway Hospital — Newburgh, Indiana (7.6 mi) · Sponsor: Biosense Webster, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07227532)

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Heart Failure and Impaired Kidney Function Phase 3 Interventional 4,800 participants sought
Research Site — Evansville, Indiana (1.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06307652)

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis Phase 3 Interventional 510 participants sought
Nektar Investigative Site — Owensboro, Kentucky (27.3 mi) · Sponsor: Nektar Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07690371)

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Plaque Psoriasis Phase 3 Interventional 3,040 participants sought
Deaconess Clinic Downtown — Evansville, Indiana (1.5 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07116967)

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Obesity, Overweight and/or Obesity Phase 3 Interventional 954 participants sought
MediSphere Medical Research Center, LLC — Evansville, Indiana (1.5 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07595549)

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma Phase 3 Interventional 269 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06500455)

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Small Cell Lung Cancer Phase 3 Interventional 531 participants sought
Deaconess Midtown Hospital /ID# 282134 — Evansville, Indiana (1.5 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07365241)

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

Peripheral Arterial Disease Phase 3 Interventional 1,205 participants sought
Deaconess Clinic- Gateway — Newburgh, Indiana (7.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07223593)

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

Moderate Aortic Valve Stenosis Phase 2, Phase 3 Interventional 1,276 participants sought
The Heart Hospital at Deaconess Gateway — Newburgh, Indiana (7.6 mi) · Sponsor: Kardigan, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07001800)

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Cardiovascular Disease Phase 3 Interventional 15,100 participants sought
Research Site — Evansville, Indiana (1.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07000357)

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Metabolic Dysfunction-Associated SteatoHepatitis (MASH) Phase 2 Interventional 120 participants sought
Deaconess Clinic - GI Specialty Center — Newburgh, Indiana (7.6 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05519475)

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

Chronic Obstructive Pulmonary Disease Phase 1 Interventional 286 participants sought
Equity Medical - Owensboro — Owensboro, Kentucky (27.3 mi) · Sponsor: Bambusa Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06944925)

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Interventional 990 participants sought
Research Site — Evansville, Indiana (1.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06878261)

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Pain N/A Observational 4,800 participants sought
Global Scientific Innovations - Advanced Pain Care Clinic — Evansville, Indiana (1.5 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT01719055)

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 630 participants sought
Owensboro Medical Health System — Owensboro, Kentucky (27.3 mi) · Sponsor: Mirati Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06875310)

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Obesity, Heart Failure Phase 3 Interventional 5,610 participants sought
Research Integrity Global, LLC — Owensboro, Kentucky (27.3 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT07567001)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Owensboro Medical Health System ( Site 0066) — Owensboro, Kentucky (27.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathic Pain Phase 3 Interventional 1,100 participants sought
Synexus Clinical Research - Evansville — Evansville, Indiana (1.5 mi) · Sponsor: Vertex Pharmaceuticals Incorporated
See eligibility & contact on ClinicalTrials.gov (NCT06628908)

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

Arthritis, Psoriatic Phase 2 Interventional 240 participants sought
Qualmedica Research — Evansville, Indiana (1.5 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07321873)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Evansville, Indiana (1.5 mi) · Sponsor: Medtronic
See eligibility & contact on ClinicalTrials.gov (NCT00271180)
Actively enrolling

Studies you may be able to join near Evansville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Evansville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

MediSphere Medical Research Center

★ 5.0
4411 Washington Ave Ste 147, Evansville, IN 47714
(812) 471-4110
"Good people who care about there people. For medical research ."
— Troy Christian, 5★

Qualmedica Research

5015 Plaza E Blvd, Evansville, IN 47715
(812) 205-2475

Clinical trials in Evansville: what's recruiting

The Evansville area currently has 66 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Evansville, the most active research areas are:

  • Heart & Vascular5 studies
  • Cancer & Oncology5 studies
  • Immune & Skin4 studies
  • Liver & Kidney4 studies
  • Lungs & Breathing4 studies

Every listing shows the study phase, the recruiting site and its distance from Evansville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Evansville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Evansville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Evansville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Evansville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Evansville, IN?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Evansville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Evansville.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Evansville typically complete one or two studies per year.

Paid clinical trials near Evansville

Other metros within reach

Clarksville, TN8 Louisville, KY566 Nashville, TN1,342 Champaign, IL169 Indianapolis, IN915 Murfreesboro, TN77 Lafayette, IN37 Springfield, IL188

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Evansville Bladder Issues Due To Spinal Cord Injury in Evansville All conditions

More of IN

Indianapolis915 Fort Wayne115 Elkhart110 South Bend110 Lafayette37

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts